Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports.Check Now!
ATS 2024 Conference: A Comprehensive Review and Analysis
- Home
- Ats Conference 2024
Day 3 Highlights of ATS 2024
Several companies showcases the encouraging results of their lead assets in the Day 3 of ATS 2024 conference to improve the current treatment landscape.
Our Recent Articles
Types / Technology
Indications
Title
Day 3 Highlights of ATS 2024
Summary
Several companies showcases the encouraging results of their lead assets in the Day 3 of ATS 2024 conference to improve the current treatment landscape.
Article Type
Clinical Trials
Title
ATS 2024 Day 2 Summary - Key Insights
Summary
Leading companies such as Sanofi, Regeneron, and others presented the encouraging results of their lead assets in Day 2 of ATS 2024.
Article Type
Clinical Trials
Title
ATS 2024 Day 1 Summary: Key Insights
Summary
Leading companies such as AstraZeneca, GSK, Amgen, and others presented their key abstracts on Day 1 of ATS 2024.
Article Type
Clinical Trials
Title
Unveiling Dupilumab's Impact: Insights from the Vestige Trial on Airway Dynamics and Mucus in Moderate-to-Severe Asthma
Summary
The emergence of dupilumab represents a promising advancement in the treatment of moderate-to-severe asthma.
Article Type
Clinical Trials
Title
TSLP and Severe Asthma: ATS 2024 Research Reveals Connections
Summary
The connection between thymic stromal lymphopoietin (TSLP) and severe asthma highlights the potential for targeted therapies to manage this chronic condition more effectively.
Article Type
Research And Development
Title
DUPIXENT’s Symphony: Raising the Curtain on the NOTUS COPD Trial
Summary
The findings from the NOTUS study underscore the profound impact DUPIXENT could have in managing COPD. By significantly improving lung function, reducing exacerbations, and potentially enhancing the quality of life
Article Type
Clinical Trials
Case Studies
Respiratory Domain Conference Coverage
Get a thorough event monitoring for a client having a portfolio around IPF
Conference Coverage Intelligence
Discover how a mid-sized European pharma company utilized ATS 2022 conference coverage
Digital Opinion Leader Analysis
Find out how a pharma company understood the landscape of DOLs in the UK related to cystic fibrosis
KOL Profiling
Learn how the engagement with respected KOLs bolstered the client's reputation as a leader in the pharma industry
Due Diligence
Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics
Newsletter and Whitepapers
Asthma Market To Advance At a Great Extent Due To Growing Prevalence of the Disease Worldwide
Asthma is a chronic disease of the air passages characterized by inflammation and narrowing of the airways. The air passages in the lungs become narrow due to inflammation and tightening of the muscles around the small airways.
Get a sneak peek of the Asthma pipeline therapies, clinical trials, deals & tie-ups, and upcoming world-class conferences, as well as track all the recent updates in the Asthma market.
Get Expert Consultation Now!
Our extensive history and deep knowledge in the field of respiratory health make us an ideal ally for addressing your urgent business challenges.
Leveraging our comprehensive understanding of the respiratory pipeline, nuanced grasp of market dynamics, and keen insight into marketing intricacies, we can assist you in devising a highly effective strategy for future success.
Reach out to us to explore potential collaboration opportunities and learn more about the valuable solutions we can provide.
Delivering value through our expansive service offerings
Considering the ever-changing nature of the respiratory therapy field, it's crucial to establish a competitive advantage for your business as soon as possible. Our range of consulting services and market research resources positions us well to guide you through obstacles while maximizing your strengths and opportunities.
We provide valuable insights to enhance your competitive edge and develop successful growth strategies. Join us on a journey to uncover opportunities and avoid pitfalls, as we simplify the process of optimizing your return on investment through our expert guidance.
Involve us to help you collect insights on which asset could hold the most potential in the future.
Our 10-year forecast provides foresight for effective strategy-building for successful market entry
Our research expertise delivers real-time information that elevates your business decisions
We assist in navigating the tricky drug development terrain by providing intelligence assessments